Rapid growth in medical device testing services market
The Medical device testing services market expected to reach USD 9.00 billion by 2030.
Read more hereProspects of in-vitro and in-vivo testing methods
Explore various in vitro and in vivo testing for biocompatibility.
Secure your placeHarmonization of medical device regulations
Discover global regulatory standards standardization for devices.
View the latest programExpert Speakers to Date
- Mike Ulman
West Pharmaceutical Services - Grant Knappe
Massachussets Institute of Technology - Nick Carrara
BD - Ashwin Singhania
Ernst & Young - Joseph Kim
ProofPilot - Karthik Raman
Persist AI Formulactions Corp. - Luke Heywood
Nest Scientfic USA - Moritz Von Stosch
DataHow AG - Martin Kachele
IDT Biologika GmbH - Lan Hu
Viome Life Sciences, Inc.
Past Attendees
- BD
- Merck
- Roche
- Human Metabolome Technologies America Inc.
- Massachusetts General Hospital
- Moderna, Inc.
- Brain Performance Center
- Massachusetts Institute of Technology
- Harvard University
- Mayo Clinic
- Seventure
- University of Wisconsin
- Icahn School of Medicine at Mount Sinai
- CLINEXEL
- Pontchartrain Cancer Center
Who should attend
- Medical Device Manufactures
- Biocompatibility Professionals
- Clinical Affairs Specialists
- Toxicology Consultants
- Healthcare Consultants
- Pharmaceutical Professionals
- Biotechnology Professionals
- Healthcare Compliance Officers
- Laboratory Professionals
- Regulatory Affairs
- Biomedical Engineering
- Logistics Professionals
- Risk Management Professionals
- Testing and Assessment
- Quality Department
- Patient Safety
- Legal Professionals
- Data Scientists and Analysts
- Equipment Certification Services
- Health Insurance
- News Reporting and Journalism
- Healthcare Organizations
- Healthcare Service Providers
- Clinical Trials Companies
- Medical Device Companies
- Post-Market Surveillance Companies
- Medical Device Testing Companies
- Biocompatibility Test Services
- Healthcare IT Companies
- Medical Startups and Innovators
- Data Analytic Companies
- Packaging and Logistics Companies
- Artificial Intelligence Companies
- Biotechnology Companies
- R&D Scientists and Engineers
- Investors and Venture Capitalists
- Government Agencies
- Consultants and Advisors
- Public Consultation Groups
- Legal and Compliance Services
- News Reporters and Journalists
- Patients and Patient Advocates
Why Attend
The MEDICAL DEVICE BIOCOMPATIBILITY USA 2024 exhibition and conference is the only event offering leading market intelligence and industry presentations on the latest advancements in medical device biocompatibility and clinical trials regulations to advance global healthcare.
view more...Subscribe for updates:
The Premier Forum for Medical Device Biocompatibility and Clinical Trials Regulations
Welcome to the MEDICAL DEVICE BIOCOMPATIBILITY USA 2024 exhibition and conference, where industry leaders will meet to explore the latest advancements in medical device biocompatibility and clinical trials regulations.
Medical device manufacturers face significant challenges, including patient safety, regulatory compliance, and risk management. Learn how to navigate premarket and post-market challenges effectively, ensuring patient safety and regulatory adherence.
Join us to harness these insights optimize your strategies and lead medical device biocompatibility.
This year’s MEDICAL DEVICE BIOCOMPATIBILITY USA 2024 will become the world's leading conference and exhibition exclusively for healthcare professionals, providing a platform to meet and collaborate with medical device biocompatibility and clinical trials experts. Participants will discover innovative methods to tackle global healthcare challenges.
Key topics on this year’s agenda include:
- Trends and innovations in biocompatible devices in healthcare
- Assessment of medical devices using innovative testing methods
- Advancing post-market surveillance of medical devices
- Latest research on identifying and assessing carcinogens
- Case studies on biological evaluation plans under guidance
- Upcoming biocompatibility regulations in the healthcare industry
This conference and exhibition will serve as a networking forum for healthcare industry stakeholders to build cross-market relationships and address challenges in medical device biocompatibility and clinical trials regulations. It focuses on mitigating toxicological risks and enhancing compliance in medical device assessments.
Call for Presentation
If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com with the subject heading "Call for Papers – MEDICAL DEVICE BIOCOMPATIBILITY USA 2024".
To secure your place at MEDICAL DEVICE BIOCOMPATIBILITY USA 2024, or if you require more information, please contact delegates@iQ-Hub.com.
Key topics for 2024:
-
Trends and innovations in biocompatible devices in healthcare
Discover the latest biocompatibility trends in the medical device lifecycle, from development to after-use. -
Assessment of medical devices using innovative testing methods
Evaluate biocompatibility, functionality, safety, performance, and environmental factors using state-of-the-art testing techniques. -
Advancing post-market surveillance of medical devices
Leverage cutting-edge technologies, such as artificial intelligence and data analytics, to transform the post-market surveillance of medical devices. -
Latest research on identifying and assessing carcinogens
Explore research on potential carcinogens, concern cohorts, and degradation products in medical devices and assess their impact. -
Case studies on biological evaluation plans under guidance
Enhance your understanding of evaluation studies to evaluate medical device compatibility with biological systems. -
Upcoming biocompatibility regulations in the healthcare industry
Stay informed about emerging regulations impacting the biocompatibility of medical devices and toxicology assessments for clinical trials.
